ATPW
RMD icon

Ashton Thomas Private Wealth’s ResMed RMD Stock Holding History

Ashton Thomas Private Wealth’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$224K Sell
1,150
-276
-19% -$57.2K ﹤0.01% 1105
2026
Q1 		$320K Buy
+1,426
New +$355K 0.01% 863
2024
Q3 		– Sell
-37
Closed -$7.08K – 1564
2024
Q2 		$7.08K Buy
+37
New +$7.51K ﹤0.01% 1438

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Ashton Thomas Private Wealth's RMD Position: Q2 2026 in Review

Ashton Thomas Private Wealth reduced its ResMed (RMD) stake by 19% in Q2 2026, selling an estimated $57.2K and leaving 1,150 shares worth $224K. The position accounts for ﹤0.01% of the portfolio, ranked #1105.

Ashton Thomas Private Wealth first reported a position in RMD in Q2 2024 and has held it in 3 quarters since. The position peaked at $320K in Q1 2026. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Ashton Thomas Private Wealth held 1,150 shares of ResMed worth $224K as of Q2 2026.
  • Ashton Thomas Private Wealth sold 276 ResMed shares in Q2 2026, an estimated $57.2K.
  • ResMed made up ﹤0.01% of Ashton Thomas Private Wealth's portfolio in Q2 2026, its #1105 holding.
  • Ashton Thomas Private Wealth first reported a position in ResMed in Q2 2024 and has held it in 3 quarters since.
  • Ashton Thomas Private Wealth's ResMed position peaked at $320K in Q1 2026.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.